Patients with CRSwNP Prefer 6-Monthly Biologic Dosing Compared with Other More Frequent Biologic Dosing Schemes

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Madison T Preib, Laura Walrave, Stefanie Kolterer, Ashley Devine-Mulligan, Nicole Thomas

DOI: 10.1016/j.jaci.2025.12.970

Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Cystic Fibrosis Research Advances Antifungal resistance and susceptibility